日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis

白藜芦醇补充剂治疗湿性年龄相关性黄斑变性：与减少玻璃体内注射次数和降低黄斑纤维化相关

期刊:
影响因子:
doi:10.2147/OPTH.S494595
Datseris, Ioannis; Rouvas, Alexandros; Tzanidaki, Malvina-Efthymia; Kardara, Marina; Geros, Vasileios; Gouliopoulos, Nikolaos
发表日期：2025
文献求助 收藏

Spontaneous resolution of photodynamic therapy-induced acute exudative maculopathy in a patient suffering from polypoidal choroidal vasculopathy: A case report with 3-year follow-up

息肉状脉络膜血管病患者光动力疗法诱发的急性渗出性黄斑病变自发消退：一例3年随访病例报告

期刊:Oman Journal of Ophthalmology
影响因子:
doi:10.4103/ojo.ojo_85_24
Rouvas, Alexandros; Georgalas, Ilias; Tzanidaki, Malvina-Efthimia; Gouliopoulos, Nikolaos
发表日期：2025
文献求助 收藏

One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration

白藜芦醇补充剂联合阿柏西普治疗与阿柏西普单药治疗湿性年龄相关性黄斑变性的一年疗效

期刊:International Journal of Ophthalmology
影响因子:1.8
doi:10.18240/ijo.2023.09.17
Datseris, Ioannis; Bouratzis, Nikolaos; Kotronis, Charalambos; Datseris, Iordanis; Tzanidaki, Malvina-Efthimia; Rouvas, Alexandros; Gouliopoulos, Nikolaos
发表日期：2023
文献求助 收藏

A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The "ELEVATE" Study

一项在希腊开展的真实世界、多中心、为期6个月的前瞻性研究，旨在评估雷珠单抗治疗对阿柏西普反应不足的年龄相关性黄斑变性患者的有效性和安全性：“ELEVATE”研究

期刊:
影响因子:
doi:10.2147/OPTH.S371036
Rouvas, Alexandros; Datseris, Ioannis; Androudi, Sofia; Tsilimbaris, Miltiadis; Kabanarou, Stamatina A; Pharmakakis, Nikolaos; Koutsandrea, Chryssanthi; Charonis, Alexander; Kousidou, Olga; Pantelopoulou, Georgia
发表日期：2022
文献求助 收藏

Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report

光动力疗法联合玻璃体内注射阿柏西普（Eylea）治疗后，伴有息肉状脉络膜血管病变的视盘黑色素细胞瘤病例报告

期刊:BMC Ophthalmology
影响因子:1.7
doi:10.1186/s12886-018-0927-7
Rouvas, Alexandros; Gouliopoulos, Nikolaos S; Moschos, Marilita M; Theodossiadis, Panagiotis
细胞生物学
发表日期：2018
文献求助 收藏

Trabeculectomy with Healaflow versus Trabeculectomy for the Treatment of Glaucoma: A Case-Control Study

青光眼治疗中，Healaflow辅助小梁切除术与单纯小梁切除术的比较：一项病例对照研究

期刊:Journal of Ophthalmology
影响因子:1.9
doi:10.1155/2015/836269
Papaconstantinou, Dimitris; Diagourtas, Andreas; Petrou, Petros; Rouvas, Alexandros; Vergados, Athanasios; Koutsandrea, Chryssanthi; Georgalas, Ilias
神经科学
青光眼
发表日期：2015
文献求助 收藏

Idiopathic retinal vasculitis, arteriolar macroaneurysms and neuroretinitis: clinical course and treatment

特发性视网膜血管炎、小动脉大动脉瘤和神经视网膜炎：临床病程和治疗

期刊:Journal of Ophthalmic Inflammation and Infection
影响因子:2.3
doi:10.1186/1869-5760-3-21
Rouvas, Alexander; Nikita, Eleni; Markomichelakis, Nikos; Theodossiadis, Panagiotis; Pharmakakis, Nikolaos
心血管
动脉瘤
发表日期：2013
文献求助 收藏

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization

玻璃体内注射雷珠单抗治疗伴有脉络膜新生血管的眼弓形虫病后，玻璃体黄斑牵引得到缓解

期刊:Therapeutics and Clinical Risk Management
影响因子:2.2
doi:10.2147/TCRM.S52161
Petrou, Petros; Georgalas, Ilias; Markomichelakis, Nikolaos; Vergados, Ioannis; Gianakaki, Emanuela; Rouvas, Alexander
微生物学
弓形虫病
发表日期：2013
文献求助 收藏

Vision loss after accidental methanol intoxication: a case report

意外甲醇中毒后视力丧失：病例报告

期刊:BMC Research Notes
影响因子:1.7
doi:10.1186/1756-0500-6-479
Moschos, Marilita M; Gouliopoulos, Nikolaos S; Rouvas, Alexandros; Ladas, Ioannis
发表日期：2013
文献求助 收藏

Twelve months of follow-up after intravitreal injection of ranibizumab for the treatment of idiopathic parafoveal telangiectasia

玻璃体内注射雷珠单抗治疗特发性黄斑旁毛细血管扩张症后12个月的随访

期刊:
影响因子:
doi:10.2147/OPTH.S44109
Rouvas, Alexandros; Malamos, Panagiotis; Douvali, Maria; Ntouraki, Amalia; Markomichelakis, Nikos N
发表日期：2013
文献求助 收藏